{"product_id":"accordant-pestle-analysis","title":"Accordant PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic cycles, and tech disruption are shaping Accordant’s strategic path in our concise PESTLE snapshot. This analysis highlights risks and opportunity levers investors and strategists need to act on today. Ready-made and research-backed, the full PESTLE delivers detailed, actionable insights—purchase now to access the complete report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eShifting federal reimbursement policy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare and Medicaid account for roughly 50% of U.S. hospital revenue, so annual CMS rulemaking—altering DRG payments, quality programs, and telehealth coverage—directly shifts demand for revenue cycle optimization. Accordant must monitor IPPS\/OPPS rule changes and recalibrate clients’ coding, documentation, and billing workflows in real time. Proactive policy monitoring is a marketable differentiator in advisory engagements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElection cycles and healthcare priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAdministrative changes can redirect funding, enforcement intensity, and incentives across value-based care and price transparency, affecting markets where Medicare enrollment reached about 66 million beneficiaries in 2024 and HHS targets 50% value-based payments by 2030. Policy volatility can shift client budgets and timing for consulting projects as enforcement (CMS price-transparency fines up to $2 million) changes. Accordant should scenario-plan for swings that impact revenue capture and compliance. Thought leadership can position clients for multi-year transitions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState-level Medicaid and regulatory diversity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eState Medicaid expansion varies—as of July 2025 forty states plus DC have expanded eligibility—while Medicaid managed care covers roughly 80% of enrollees nationally, and state HIE and interoperability policies differ widely. Multi-state health systems therefore need localized documentation and billing compliance. Accordant can tailor state-specific playbooks for prior auth, coverage rules, and audit defense. Local policy intelligence shortens time-to-ROI by reducing denials and accelerating reimbursements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment price transparency and competition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment price-transparency rules (CMS rule effective Jan 1, 2021) pressure margins and expose pricing strategies; commercial rates commonly run 2–3x Medicare and CMS may levy civil monetary penalties up to $300\/day for noncompliance. Increased scrutiny drives revenue integrity and CDI to justify charges; Accordant can align documentation to clinical severity and support fair pricing narratives amid consolidation pressures.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCMS rule effective 2021\u003c\/li\u003e\n\u003cli\u003eCommercial rates ~2–3x Medicare\u003c\/li\u003e\n\u003cli\u003ePenalties up to $300\/day\u003c\/li\u003e\n\u003cli\u003eConsolidation raises integration need\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health preparedness funding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolicy emphasis on preparedness, backed by CDC PHEP funding near $700 million annually, drives hospitals to invest in data, analytics, and reporting to meet requirements; federal grants and DMI-era allocations (roughly $1 billion directed to data modernization efforts) subsidize HIM upgrades and interoperability projects. Accordant helps map preparedness metrics to documentation standards, linking compliance to operational resilience and reimbursement pathways.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePreparedness funding: CDC PHEP ≈ $700M\u003c\/li\u003e\n\u003cli\u003eData modernization: ≈ $1B in federal allocations\u003c\/li\u003e\n\u003cli\u003eImpact: grants finance HIM\/interoperability\u003c\/li\u003e\n\u003cli\u003eAccordant role: map metrics to documentation for compliance + reimbursement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e\n\u003cstrong\u003e≈50%\u003c\/strong\u003e Medicare\/Medicaid revenue prompts RCM \u0026amp; HIM investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMedicare\/Medicaid ≈50% of hospital revenue; 66M Medicare beneficiaries (2024) shift demand for revenue-cycle optimization. As of July 2025, 40 states+DC expanded Medicaid; state rules require localized billing playbooks. Price-transparency enforcement (penalties ≈$300\/day; CMS fines up to $2M) and preparedness\/data funding drive investment in HIM and interoperability.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare\/Medicaid share\u003c\/td\u003e\n\u003ctd\u003e≈50%\u003c\/td\u003e\n\u003ctd\u003eRevenue sensitivity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare beneficiaries\u003c\/td\u003e\n\u003ctd\u003e66M (2024)\u003c\/td\u003e\n\u003ctd\u003eDemand for optimization\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid expansion\u003c\/td\u003e\n\u003ctd\u003e40 states + DC (Jul 2025)\u003c\/td\u003e\n\u003ctd\u003eLocal compliance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice-transparency penalty\u003c\/td\u003e\n\u003ctd\u003e≈$300\/day\u003c\/td\u003e\n\u003ctd\u003eCompliance spend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS fines\u003c\/td\u003e\n\u003ctd\u003eUp to $2M\u003c\/td\u003e\n\u003ctd\u003eRisk exposure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCDC PHEP\u003c\/td\u003e\n\u003ctd\u003e≈$700M\u003c\/td\u003e\n\u003ctd\u003ePreparedness funding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData modernization\u003c\/td\u003e\n\u003ctd\u003e≈$1B\u003c\/td\u003e\n\u003ctd\u003eHIM\/interoperability investment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect the Accordant across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with each category expanded into detailed, business-specific sub-points. Every section is backed by current data and forward-looking insights to support executives, consultants, and entrepreneurs in scenario planning, risk mitigation, and opportunity identification.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA compact, editable PESTLE snapshot organized by category for quick sharing in meetings, presentations, or client reports—uses plain language and visual segmentation to speed alignment and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMargin pressure and cost containment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising labor, supply and drug costs have pushed many U.S. hospitals into negative operating margins (median negative in 2023), while revenue cycle leakage—commonly 3–5% of gross revenue—now threatens cash flow. Accordant’s RCM optimization and denial-prevention programs deliver rapid payback by recapturing net revenue. Business cases tied to projected net revenue lift and ROI drive faster approvals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayer mix shifts and bad debt risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eShifts toward public payers—now roughly half of the U.S. payer mix—compress yields versus commercial rates while patient responsibility has climbed (average single-plan deductible ~$1,760 in 2023). Economic slowdowns drive higher uncompensated care and tougher collections; Accordant builds patient financial engagement and propensity-to-pay pathways, plus enhanced eligibility and documentation workflows to help stabilize cash and reduce bad debt.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation and integration waves\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWaves of M\u0026amp;A, joint ventures and physician practice acquisitions have pushed over 50% of US physicians into system employment, creating highly fragmented RCM and HIM stacks. Integration demands standardized policies, coding and KPIs across sites; Accordant can lead PMOs to harmonize EHR workflows and charge capture. Realizing synergies—often a mid-single-digit to low-double-digit percent revenue improvement—depends on disciplined CDI and revenue integrity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital constraints and ROI scrutiny\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHigher interest rates (Federal funds target 5.25–5.50% as of July 2025) and tighter corporate balance sheets delay large IT purchases, forcing ROI scrutiny and prioritization of near-term paybacks. Consulting engagements must demonstrate quick wins and staged benefits; Accordant can adopt phased delivery with shared-savings or value-based pricing to de-risk buys. Benchmarking and dashboards validate financial impact and support renewal decisions.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePhased delivery: reduces upfront capex\u003c\/li\u003e\n\u003cli\u003eShared-savings: aligns incentives\u003c\/li\u003e\n\u003cli\u003eDashboards: prove ROI monthly\/quarterly\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-based payment and risk contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eShift to bundled payments and ACO models ties revenue to outcomes and documentation; as of 2024 CMS ACOs cover \u0026gt;12 million beneficiaries and bundled-payment pilots reported 5–10% episode cost reductions. Accurate risk adjustment and HCC capture act as economic levers—better capture can raise risk-adjusted revenue by up to ~10–15% per patient. Accordant can align CDI with quality and utilization metrics to support both fee-for-service and risk-based streams.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue tied to outcomes: \u0026gt;12M ACO beneficiaries (2024)\u003c\/li\u003e\n\u003cli\u003eEpisode savings: 5–10% in bundled pilots\u003c\/li\u003e\n\u003cli\u003eHCC capture: potential +10–15% risk-adjusted revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e\n\u003cstrong\u003e≈50%\u003c\/strong\u003e Medicare\/Medicaid revenue prompts RCM \u0026amp; HIM investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRising labor, supply and drug costs pushed many U.S. hospitals to median negative operating margins in 2023 while revenue leakage (3–5% of gross rev) stresses cash; Accordant’s RCM\/denial programs recapture net revenue with rapid payback. Public payers now ~50% of mix and patient deductibles (~$1,760 in 2023) raise bad debt; Accordant strengthens financial engagement and eligibility. Higher rates (Fed 5.25–5.50% Jul 2025) force phased, ROI-driven deployments and shared-savings models.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue leakage\u003c\/td\u003e\n\u003ctd\u003e3–5%\u003c\/td\u003e\n\u003ctd\u003eCash pressure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic payer mix\u003c\/td\u003e\n\u003ctd\u003e~50%\u003c\/td\u003e\n\u003ctd\u003eLower yields\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg deductible\u003c\/td\u003e\n\u003ctd\u003e$1,760 (2023)\u003c\/td\u003e\n\u003ctd\u003eHigher patient liability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50% (Jul 2025)\u003c\/td\u003e\n\u003ctd\u003eCapex scrutiny\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eACO reach\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;12M (2024)\u003c\/td\u003e\n\u003ctd\u003eRisk-based revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eAccordant PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Accordant PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use. No placeholders or teasers: the content, layout, and insights visible now are the final document you’ll download instantly after payment. This is the real product, delivered exactly as shown.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162583708025,"sku":"accordant-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/accordant-pestle-analysis.png?v=1762703863","url":"https:\/\/portersfiveforce.com\/products\/accordant-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}